(August 12, 2016) -- The Federal Trade Commission was quick to highlight that it had required global pharmaceutical giant Teva to unload 79 generic drugs — the largest drug divestiture in one of its cases — before allowing the company to consummate its $40.5 billion deal for Allergan’s generic business....